摘要
1例右肺癌患者经纳武利尤单抗治疗后8个月暴发罕见的免疫性心肌炎、免疫性脑炎、免疫性肺炎、免疫性垂体功能减退、免疫性血小板减少、免疫性肝炎的多系统免疫不良反应。分析其病例特征,并与其他免疫检查点抑制剂引起的多系统免疫相关不良事件异同点进行讨论。
After an 8-month therapy of nivolumab,one patient of right lung carcinoma had a rare outbreak of multisystem immune adverse reactions such as immune myocarditis,immune encephalitis,immune pneumonia,immune hypopituitarism,immune thrombocytopenia and immune hepatitis.The clinical characteristics of this case were analyzed along with the similarities and differences with other multi-system immune-related adverse events due to immune checkpoint inhibitors.
作者
孙玲玲
周广洁
张丽娜
李进峰
SUN Lingling;ZHOU Guangjie;ZHANG Lina;LI Jinfeng(Department of Pharmacy,Municipal Hospital,Shandong University,Shandong Weihai 264200,China)
出处
《中国医院药学杂志》
CAS
北大核心
2024年第11期1359-1362,共4页
Chinese Journal of Hospital Pharmacy